<DOC>
	<DOCNO>NCT02035839</DOCNO>
	<brief_summary>To assess fraction subject survive good neurological outcome 90 day 3 different level hypothermia , comatose survivor out-of-hospital cardiac arrest .</brief_summary>
	<brief_title>Finding Optimal Cooling tempeRature After Out-of-HoSpiTal Cardiac Arrest</brief_title>
	<detailed_description />
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
	<criteria>Signed informed consent ( obtained legal representative ) 18 year age old less 80 year old . Witnessed OHCA presume cardiac cause Sustained ROSC ( chest compression require 20 consecutive minute sign circulation persist ) Initial shockable cardiac rhythm ( document ECG AED ) Interval collapse advance life support &lt; 20 minute Interval collapse ROSC &lt; 60 minute Lack meaningful response verbal command upon arrival hospital suffer nontraumatic cardiac arrest outofhospital set Systolic blood pressure &gt; 90 maintain least 30 minute postROSC without pressor , stable dose pressor Traumatic cardiac arrest Toxicological etiology Known suspect pregnancy Do Not Attempt Resuscitate order force Unwitnessed arrest InHospital arrest Anatomy , previous surgery disease state contraindicate femoral venous access Received neuromuscular blocking agent prior assess level consciousness follow ROSC Neurological evaluation insufficient/incomplete ROSC prior randomization . Body core temperature &lt; 34ºC randomization Current Inferior Vena Cava ( IVC ) filter Known history acute neurological illness severe functional disability prior arrest ( e.g. , seizure , traumatic brain injury , increase intracranial pressure , intracerebral hemorrhage , etc ) . Known hypersensitivity hypothermia include history Raynaud 's disease Suspected confirm acute intracranial bleeding Suspected confirm acute stroke Terminal illness life expectancy le 3 month prior arrest Currently enrol another investigational new drug device trial complete primary endpoint clinically interfere Trial 's endpoint ( For purpose protocol , subject involve extended followup trial registry product currently commercially available consider enrol investigational trial ) . Transferred nonparticipating hospital .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Target Temperature Management</keyword>
	<keyword>Cooling comatose survivor OHCA</keyword>
	<keyword>Good neurological outcome modify Rankin Score ( mRS ) ≤ 3</keyword>
</DOC>